S-1 versus S-1 plus cisplatin concurrent intensity modulated radiation therapy in the treatment of esophageal squamous cell carcinoma: Study protocol for a randomized controlled phase II trial.

about

S-1 versus S-1 plus cisplatin concurrent intensity modulated radiation therapy in the treatment of esophageal squamous cell carcinoma: Study protocol for a randomized controlled phase II trial.

Item

http://www.wikidata.org/entity/Q47129248

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

S-1 versus S-1 plus cisplatin ...... zed controlled phase II trial.

@en

S-1 versus S-1 plus cisplatin ...... zed controlled phase II trial.

@nl

type

Item

label

S-1 versus S-1 plus cisplatin ...... zed controlled phase II trial.

@en

S-1 versus S-1 plus cisplatin ...... zed controlled phase II trial.

@nl

prefLabel

S-1 versus S-1 plus cisplatin ...... zed controlled phase II trial.

@en

S-1 versus S-1 plus cisplatin ...... zed controlled phase II trial.

@nl

P1476

S-1 versus S-1 plus cisplatin ...... zed controlled phase II trial.

@en

P2093

Chen Yang

http://www.w3.org/2001/XMLSchema#string

Dongbiao Liao

http://www.w3.org/2001/XMLSchema#string

Honggang Tian

http://www.w3.org/2001/XMLSchema#string

Jidong Miao

http://www.w3.org/2001/XMLSchema#string

Mingqiang Sun

http://www.w3.org/2001/XMLSchema#string

Qiang Jia

http://www.w3.org/2001/XMLSchema#string

Qilin Yang

http://www.w3.org/2001/XMLSchema#string

Xiaobo Du

http://www.w3.org/2001/XMLSchema#string

Yan Gui

http://www.w3.org/2001/XMLSchema#string

Yixue Wen

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics, 2012

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

Esophageal cancer: definitive chemoradiotherapy for elderly patients.

Concurrent chemoradiotherapy with a novel fluoropyrimidine, S-1, and cisplatin for locally advanced esophageal cancer: long-term results of a phase II trial.

Phase I/II trial of chemoradiotherapy with concurrent S-1 and cisplatin for clinical stage II/III esophageal carcinoma (JCOG 0604)

Efficacy and feasibility of ambulatory treatment-based monthly nedaplatin plus S-1 in definitive or salvage concurrent chemoradiotherapy for early, advanced, and relapsed esophageal cancer.

A phase I dose escalation study of S-1 with concurrent radiotherapy in elderly patients with esophageal cancer

Esophageal cancer: A Review of epidemiology, pathogenesis, staging workup and treatment modalities.

Oesophageal carcinoma.

An audit of the treatment of cancer of the oesophagus.

P304

e8998

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MD.0000000000008998

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29245275

http://www.w3.org/2001/XMLSchema#string

P921

phase II clinical trial

P932

5728890

http://www.w3.org/2001/XMLSchema#string